Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Spondweni virus (SPOV) is the flavivirus that is most closely related to Zika virus (ZIKV). Although SPOV causes sporadic human infections in Africa, recently it was found in Culex mosquitoes in Haiti. To investigate the pathogenic spectrum of SPOV, we developed infection models in mice. Although two SPOV strains failed to cause disease in immunocompetent mice, each accumulated in the brain, spleen, eye, testis, and kidney when type I interferon signaling was blocked and unexpectedly caused infection, immune cell infiltration, and swelling in the ankle. In pregnant mice, SPOV replicated in the placenta and fetus but did not cause placental insufficiency or microcephaly. We identified human antibodies from ZIKV or DENV immune subjects that neutralized SPOV infection and protected against lethal challenge. Our experiments describe similarities and differences in clinical syndromes between SPOV and ZIKV and suggest that their serological relatedness has implications for antibody therapeutics and flavivirus vaccine development.

Original publication

DOI

10.1016/j.celrep.2019.01.052

Type

Journal article

Journal

Cell Rep

Publication Date

05/02/2019

Volume

26

Pages

1585 - 1597.e4

Keywords

Dengue virus, Spondweni virus, Zika virus, antibody therapy, arthritis, flavivirus, immunity, pathogenesis, Animals, Antibodies, Monoclonal, Antibodies, Neutralizing, Antibodies, Viral, Cells, Cultured, Cross Reactions, Dengue Virus, Female, Flavivirus Infections, Humans, Male, Mice, Mice, Inbred C57BL, Zika Virus